OUR PRODUCTS

MOBILE APPS

GENERAL INFO

PRTA

Stock ticker: NASDAQ

PRICE

CHANGE

CAPITALIZATION

Prothena (PRTA) Earnings Date & Reports

Prothena Corp PLC is a clinical biotechnology company that focuses on protein dysregulation and a pipeline of investigational therapeutics with the potential to change the course of devastating neurodegenerative and rare and peripheral amyloid diseases... Show more

Industry: #Biotechnology

Get AI intraday signals

A.I. Advisor

published Earnings

PRTA is expected to report earnings to fall 62.02% to -88 cents per share on October 30

Q3'25

Est.

$-0.89

Q2'25

Missed

by $1.12

Q1'25

Beat

by $0.11

Q4'24

Missed

by $0.08

Q3'24

Beat

by $0.08

The last earnings report on August 04 showed earnings per share of -233 cents, missing the estimate of -122 cents. With 151.96K shares outstanding, the current market capitalization sits at 413.95M.

View a ticker or compare two or three

Compare

PRTA

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if bought

View Trends For PRTA
(Try 14 days for Free)

Interact to see
Advertisement

A.I.Advisor

published price charts

These past five trading days, the stock lost 0.00% with an average daily volume of 0 shares traded.The stock tracked a drawdown of 0% for this period. PRTA showed earnings on August 04, 2025. You can read more about the earnings report here.

View AI-Driven Trading

A.I. Advisor

published General Information

General Information

a developer of novel antibodies

Industry Biotechnology

Profile

Fundamentals

Details

Industry

Biotechnology

Address

77 Sir John Rogersonâ€™s Quay

Phone

+353 12362500

Employees

173

Web

https://www.prothena.com